3R6W
paAzoR1 binding to nitrofurazone
Summary for 3R6W
Entry DOI | 10.2210/pdb3r6w/pdb |
Related | 2V9C 3KEG 3LT5 |
Descriptor | FMN-dependent NADH-azoreductase 1, FLAVIN MONONUCLEOTIDE, NITROFURAZONE, ... (6 entities in total) |
Functional Keywords | azoreductase, nitrofurazone, p. aeruginosa, nitroreductase, short-flavodoxin, oxidoreductase |
Biological source | Pseudomonas aeruginosa |
Total number of polymer chains | 2 |
Total formula weight | 48203.83 |
Authors | Ryan, A.,Kaplan, K.,Laurieri, N.,Lowe, E.,Sim, E. (deposition date: 2011-03-22, release date: 2011-08-24, Last modification date: 2023-09-13) |
Primary citation | Ryan, A.,Kaplan, E.,Laurieri, N.,Lowe, E.,Sim, E. Activation of nitrofurazone by azoreductases: multiple activities in one enzyme. Sci Rep, 1:63-63, 2011 Cited by PubMed Abstract: Azoreductases are well known for azo pro-drug activation by gut flora. We show that azoreductases have a wider role in drug metabolism than previously thought as they can also reduce and hence activate nitrofurazone. Nitrofurazone, a nitroaromatic drug, is a broad spectrum antibiotic which has until now been considered as activated in bacteria by nitroreductases. The structure of the azoreductase with nitrofurazone bound was solved at 2.08 Å and shows nitrofurazone in an active conformation. Based on the structural information, the kinetics and stoichiometry of nitrofurazone reduction by azoreductase from P. aeruginosa, we propose a mechanism of activation which accounts for the ability of azoreductases to reduce both azo and nitroaromatic drugs. This mode of activation can explain the cytotoxic side-effects of nitrofurazone through human azoreductase homologues. PubMed: 22355582DOI: 10.1038/srep00063 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.085 Å) |
Structure validation
Download full validation report